Suppr超能文献

测定血液和尿液基质中的羟考酮及其主要代谢物:传统采样方法与微型化采样方法的比较。

Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.

机构信息

Pharmaco-Toxicological Analysis Laboratory, Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy.

Pharmaco-Toxicological Analysis Laboratory, Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Department of Pharmacology and Toxicology, Charles University, Hradec Králové, Czech Republic.

出版信息

J Pharm Biomed Anal. 2018 Apr 15;152:204-214. doi: 10.1016/j.jpba.2018.01.043. Epub 2018 Jan 31.

Abstract

Oxycodone is a widely prescribed, full agonist opioid analgesic. As such, it is used clinically to treat different kinds of painful conditions, with a relatively high potential for doping practices in athletes. In this paper, different classic and innovative miniaturised matrices from blood and urine have been studied and compared, to evaluate their relative merits and drawbacks within therapeutic drug monitoring (TDM) and to implement new protocols for anti-doping analysis. Plasma, dried blood spots (DBS) and dried plasma spots (DPS) have been studied for TDM purposes, while urine, dried urine spots (DUS) and volumetric absorptive microsamples (VAMS) from urine for anti-doping. These sampling techniques were coupled to an original bioanalytical method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the evaluation and monitoring of the levels of oxycodone and its major metabolites (noroxycodone and oxymorphone) in patients under pain management and in athletes. The method was validated according to international guidelines, with good results in terms of precision, extraction yield and accuracy for all considered micromatrices. Thus, the proposed sampling, pre-treatment and analysis are attractive strategies for oxycodone determination in human blood and urine, with advanced options for application to derived micromatrices. Microsampling procedures have significant advantages over classic biological matrices like simplified sampling, storage and processing, but also in terms of precision (<9.0% for DBS, <7.7% for DPS, <7.1% for DUS, <5.3% for VAMS) and accuracy (>73% for DBS, >78% for DPS, >74% for DUS, >78% for VAMS). As regards extraction yield, traditional and miniaturised sampling approaches are comparable (>67% for DBS, >74% for DPS, >75% for DUS, >75% for VAMS). All dried matrices have very low volumes, leading to a significant advantage in terms of analysis feasibility. On the other hand, this also leads to a corresponding decrease in the overall sensitivity.

摘要

羟考酮是一种广泛应用的完全激动型阿片类镇痛药。因此,它在临床上被用于治疗各种疼痛病症,并且在运动员中具有较高的滥用潜力。本文研究并比较了不同经典和创新的血液和尿液微型基质,以评估它们在治疗药物监测(TDM)中的相对优缺点,并实施新的反兴奋剂分析方案。已经研究了血浆、干血斑(DBS)和干血浆斑(DPS)用于 TDM 目的,而尿液、干尿斑(DUS)和尿液体积吸收微样本(VAMS)用于反兴奋剂。这些采样技术与一种基于液相色谱-串联质谱(LC-MS/MS)的原始生物分析方法相结合,用于评估和监测接受疼痛管理的患者和运动员体内羟考酮及其主要代谢物(去羟考酮和羟吗啡酮)的水平。该方法按照国际指南进行了验证,所有考虑的微型基质的精密度、提取率和准确度均取得了良好的结果。因此,所提出的采样、预处理和分析策略对于人血和尿中羟考酮的测定具有吸引力,并为衍生微型基质的应用提供了先进的选择。与经典生物基质相比,微型采样具有简化采样、储存和处理等显著优势,同时在精密度(DBS <9.0%,DPS <7.7%,DUS <7.1%,VAMS <5.3%)和准确度(DBS >73%,DPS >78%,DUS >74%,VAMS >78%)方面也具有优势。就提取率而言,传统和微型采样方法具有可比性(DBS >67%,DPS >74%,DUS >75%,VAMS >75%)。所有干基质的体积都非常小,在分析可行性方面具有显著优势。另一方面,这也导致整体灵敏度相应降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验